Literature DB >> 42024

Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.

D S Robinson, I C Campbell, M Walker, N J Statham, W Lovenberg, D L Murphy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42024     DOI: 10.1016/0028-3908(79)90021-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  6 in total

Review 1.  Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors:  G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

2.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.

Authors:  I C Campbell; D L Murphy; M N Walker; W Lovenberg; D S Robinson
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  Effects of subchronic administration of antidepressants and anxiolytics on levels of the alpha subunits of G proteins in the rat brain.

Authors:  Y Dwivedi; G N Pandey
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.

Authors:  R T Coutts; T S Rao; G B Baker; R G Micetich; T W Hall
Journal:  Cell Mol Neurobiol       Date:  1987-09       Impact factor: 5.046

6.  Effects of growing tumours on pineal melatonin levels in male rats.

Authors:  V Lapin; A Frowein
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.